Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-034185
Filing Date
2025-03-06
Accepted
2025-03-06 08:07:22
Documents
78
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rapt-20241231.htm   iXBRL 10-K 2803370
2 EX-19.1 rapt-ex19_1.htm EX-19.1 86535
3 EX-23.1 rapt-ex23_1.htm EX-23.1 7665
4 EX-31.1 rapt-ex31_1.htm EX-31.1 16023
5 EX-31.2 rapt-ex31_2.htm EX-31.2 15918
6 EX-32.1 rapt-ex32_1.htm EX-32.1 8641
7 EX-32.2 rapt-ex32_2.htm EX-32.2 8551
8 GRAPHIC img57771353_0.jpg GRAPHIC 146519
9 GRAPHIC img57771353_1.jpg GRAPHIC 40776
10 GRAPHIC img57771353_2.jpg GRAPHIC 51792
11 GRAPHIC img57771353_3.jpg GRAPHIC 155919
12 GRAPHIC img57771353_4.jpg GRAPHIC 55800
  Complete submission text file 0000950170-25-034185.txt   11049057

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapt-20241231.xsd EX-101.SCH 1227028
81 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20241231_htm.xml XML 1637088
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38997 | Film No.: 25713668
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)